Abstract:D-dimer is a biomarker of coagulation and fibrinolytic system activation in response to the hypercoagulable state of the body. The research aimed to analyze the value of D-dimer in the prognosis of patients with dilated cardiomyopathy (DCM). Patients admitted to our center for the first time with DCM were enrolled consecutively. The clinical characteristics variables were obtained from the electronic medical record system, and the prognostic information was obtained using telephone return visits and a review of repeated hospitalization records. Univariate and multivariate Cox regression was used to explore the association of D-dimer with all-cause mortality. Smooth curve fitting, threshold saturation effect analysis, and subgroup analysis were performed. Ultimately, 534 patients were included. After a follow-up of the enrolled patients, 485 patients obtained prognostic information, of which 159 died from all causes, and the main cause of death was heart failure (89/159), the sudden death accounted for about 17%. The independent positive association between D-dimer and all-cause mortality remained unchanged in both unadjusted and adjusted Cox regression models. In the fully adjusted model, each standard deviation increase in D-dimer was associated with a 14% increase in all-cause mortality (HR = 1.14; 95% CI: 1.02 ~ 1.27; P < 0.05). Curve fitting and threshold effect analysis showed an inflection point in the relationship between D-dimer and all-cause mortality (non-linear test: P = 0.03). When D-dimer was equal to 362ng/ml, HR = 1; and as the value increased, the risk of all-cause mortality increased by 34.7% for every 2-fold increase in D-dimer gradually (HR = 1.347; 95% CI: 1.069 ~ 1.697; P = 0.012). In subgroup analysis, D-dimer and BMI had a significant interaction on all-cause mortality, with a significantly increased risk of all-cause mortality in subjects with BMI ≥ 25 kg/m 2 (HR = 1.99; 95% CI: 1.34 ~ 2.97; P < 0.01). The ROC curve showed that D-dimer was a good predictor of all-cause mortality, and the areas under the curve at 1-, 3-, and 5-year were 0.71, 0.64, and 0.59, respectively. In addition, D-dimer improved the predictive performance of the MAGGIC heart failure score in patients with DCM. D-dimer is not only independently associated with all-cause mortality in DCM patients, but also has good predictive value, suggesting that D-dimer may be an early and useful marker for improving the management of DCM patients.

Clinical significance of D-dimer and fibrinogen in early diagnosis of coronary heart disease

The Diagnosis Significance of Assays of Hs-Crp and D-dimeride in Early Diagnosis of CAD

Correlation between plasma fibrinogen and D-dimer level and pathological changes of coronary artery

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Change and Significance of D-Dimer and Platelet Glycoprotein IIb/IIIa in Patients with Various Types of Coronary Heart Disease

[The Changes and Their Clinical Significance of D-dimer and Platelet Glycoprotein in Patients with Coronary Heart Disease].

D-Dimer to Fibrinogen Ratio As a Novel Prognostic Marker in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.

Levels of fibrinogen, D-Dimer and high-sensitivity C-reactive protein in serum of patients with coronary atherosclerotic heart disease

Study on pathogenesis of plasma coagulation factors on coronary heart disease

ASSA13-11-11 Should the D-Dimer Be Acted As a Useful Marker for Acute Myocardial Infarction?

The predictive values of D-dimer for the early prognosis of the acute myocardial infarction (AMI): a review of 3134 AMI patients

[The value of D-dimer for etiological diagnosis of mortal chest pain: an analysis of 438 cases].

The Clinical Significance of Combined Testing of Plasma Fibrinogen and D-dimer in Pulmonary Embolism Patients

Ratio of D-dimer to high-sensitivity troponin Ⅰ and fibrinogen in diagnosis of fatal chest pain

Clinical Study of Hypercoagulation in Coronary Disease Patients with Noninsulin Dependent Diabetes Mellitus

Clinical Significance of D-dimer in Rapid Screening for Acute Aortic Dissection

Diagnostic Implication of Fibrin Degradation Products and D-Dimer in Aortic Dissection

The use of d-dimer in the diagnosis and risk assessment of intracardiac thrombus among patients with dilated cardiomyopathy

The value of D-dimer in the prognosis of dilated cardiomyopathy: a retrospective cohort study

The Correlationship of Plasma Lipoprotein-Associated Phospholipase A2, Hypersensitive C-reactive Protein and D-dimer in Coronary Artery Disease Patients

Prognostic significance of D-dimer and fibrinogen degradation products in acute pulmonary embolism